Market News AIOpen the app

INO stock news · Inovio Pharmaceuticals

Stories about Inovio Pharmaceuticals (INO) from the last 90 days, each explained in plain English with whether the news reads good or bad for the company.

Get alerts for INO

Follow Inovio Pharmaceuticals (INO) free. When we publish a story about it, you get the plain-English explanation as an alert.

Get alerts for INO
Free on the App Store and Google Play, or on the web.
  1. Oct 31, 2026, 9:42 AM ET · Trial

    Inovio got quick approval from the FDA for VOCERYQ, a treatment for a throat condition.

    Good for INO

    Inovio received FDA approval for VOCERYQ, creating a path to sales. A required follow-up study remains, but this approval is a clear positive for the company.

  2. Oct 30, 2026, 5:23 PM ET · Market

    On Friday evening, 12 health care stocks changed a lot in price, with Inovio up 292.6% and Precigen down 26.5%.

    Neutral

    Inovio shares rose 293% in Friday's after-hours session, but the article gives no new company news. The move alone does not change how we read its business outlook.

  3. Oct 20, 2026, 5:16 PM ET · Market

    12 health care stocks changed a lot after the market closed on Tuesday.

    Neutral

    Inovio Pharmaceuticals shares rose 7.92%, but the report gives no new company results or business news. The share move alone does not change its business outlook.